Avanir to pay $116M for engaging in kickback scheme

Pharmaceuticals

Avanir Pharmaceuticals will pay a combined $116 million in civil and criminal penalties for paying kickbacks to a physician to induce prescriptions of its drug Nuedexta, the Department of Justice announced.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.